Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 3886 AL 3900

Trained immunity in acute and chronic neurological diseases

Zhang S, Liesz A.

Elife. 2026 Jan 15;15:e106037. doi: 10.7554/eLife.106037.

Effectiveness of Blood Flow Restriction Training in Neurological Rehabilitation: A Systematic Review and Meta-analysis

Wang H, Cao Y, Zhang J, Chen L, Liang D, Fang L, Qian Y, Huang G, Song L, Jia J.

Sports Med Open. 2026 May 6;12(1):53. doi: 10.1186/s40798-026-01022-z.

Research hotspots and trends in electrical stimulation for movement disorders: a bibliometric analysis from 2016 to 2025

Liu A, Shu Z, Wen J, Cui X, Shi Y, Geng S.

Front Aging Neurosci. 2026 Apr 23;18:1793056. doi: 10.3389/fnagi.2026.1793056. eCollection 2026.

When caution becomes neglect: Deep brain stimulation and cognitive impairment in Parkinson's disease

Lewis SJ.

J Parkinsons Dis. 2026 May;16(3):599-603. doi: 10.1177/1877718X261428282. Epub 2026 Feb 27.

Focused Ultrasound for the Treatment of Circuit and Molecular Pathology in Parkinson's Disease

Kofoed RH, Hvingelby VS, Pineda-Pardo JA, Blesa J, Paschen S, Tandon A, Joutsa J, Glud AN.

Mov Disord. 2026 Apr;41(4):826-842. doi: 10.1002/mds.70156. Epub 2026 Feb 3.

Differentiating between the impact of sex and gender in Parkinson's disease: utilising these to advance current understanding and care practices

Thatcher TBC, Sharrad S, Bobrovskaya L.

Neurol Sci. 2026 Jan 7;47(1):117. doi: 10.1007/s10072-025-08650-5.

Management of Parkinson's disease psychosis-a European perspective

Pirker W, Ferreira JJ, Rascol O, Poewe W.

Lancet Reg Health Eur. 2026 Jan 5;62:101569. doi: 10.1016/j.lanepe.2025.101569. eCollection 2026 Mar.

Beyond motor control: The subthalamic nucleus as a central hub for pain in Parkinson's disease

Molpeceres-Sierra E, Bouali-Benazzouz R, Fossat P, Benazzouz A.

Neurosci Biobehav Rev. 2026 Jul;186:106691. doi: 10.1016/j.neubiorev.2026.106691. Epub 2026 Apr 17.

Re-conceptualizing Parkinson's disease as a lifelong neurobiological trajectory: A framework for prevention

Ajibare AJ, Asuku AO, Akintoye OO.

Neuroprotection. 2026 Feb 25;4(1):14-29. doi: 10.1002/nep3.70030. eCollection 2026 Mar.

Neuroprotective role of cyanidin in Alzheimer's and Parkinson's disease: current insights and the road ahead

Bashir B, Andotra N, Sharma P, Sharma T, Chauhan S, Awasthi A, Singh S, Singh TG, Singh SK, Vishwas S.

Inflammopharmacology. 2026 May 23. doi: 10.1007/s10787-026-02271-w. Online ahead of print.

Neurodegeneration at the crossroads: the gut-brain axis and blood-brain barrier in Parkinson's disease - a review

Gamal NK, Fakhry R, Hatem Y, Rashed E, Marzouk R, Bukr AKM, Akawi N, George MY.

Front Pharmacol. 2026 May 8;17:1813134. doi: 10.3389/fphar.2026.1813134. eCollection 2026.

Research Progress of Natural Components Improving Parkinson's Disease by Regulating the Oxidative Stress

Jiang W, Li Z, Hu M, Zhang H, Tian X, Chen Q, Zhao Y, Xu K, Qu Y, Wei S, Wang X, Geng X.

Phytother Res. 2026 Apr;40(4):1810-1836. doi: 10.1002/ptr.70214. Epub 2026 Feb 1.

Mechanistic insights into the role of nuclear receptor related-1 protein in Parkinson's disease

Sharma V, Singh TG.

J Neuroimmunol. 2026 May;414:578893. doi: 10.1016/j.jneuroim.2026.578893. Epub 2026 Feb 16.

Sources of Oxidative Stress in Parkinson's Disease: Pathways and Therapeutic Implications

Yordanov Y, Stefanova D, Kondeva-Burdina M, Tzankova V.

Antioxidants (Basel). 2026 Feb 2;15(2):187. doi: 10.3390/antiox15020187.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias